Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface
- PMID: 3487355
Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface
Abstract
Previously we have shown that both factor XI and factor XIa are bound specifically to distinct, high-affinity sites on the surface of activated platelets in the presence of high Mr kininogen. To determine the functional significance of factor XIa binding to platelets, bound factor XIa has now been compared with the unbound enzyme. Platelets incubated with thrombin, high Mr kininogen, and 125I-labeled factor XIa bound 130 to 500 molecules of factor XIa per platelet. Scatchard analysis of binding data give a dissociation constant (Kd) of 822 pmol/L +/- 140 (SEM). Rates of factor IX activation, assayed by release of trichloroacetic acid-soluble 3H-labeled activation peptide from purified [3H]-factor IX, were similar when factor XIa was bound to platelets and when it was free in solution. The platelet-bound factor XIa was isolated by centrifugation through 20% sucrose and was functionally characterized both in a factor XIa coagulation assay and in the factor IX activation peptide release assay in comparison with unbound factor XIa in the presence of treated platelets. The functional activity of platelet-bound factor XIa as a factor IX activator as well as its structural integrity were shown to be fully retained on the platelet surface. Since platelets bind factor XI and promote its proteolytic activation to factor XIa, factor XIa binding to platelets may serve to localize factor IX activation to the hemostatic plug, where factor XIa is protected from inactivation by plasma protease inhibitors and where acceleration of subsequent coagulation reactions can occur.
Similar articles
-
Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.J Clin Invest. 1987 Dec;80(6):1578-86. doi: 10.1172/JCI113244. J Clin Invest. 1987. PMID: 3500185 Free PMC article.
-
Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.J Biol Chem. 1992 Oct 5;267(28):19833-9. J Biol Chem. 1992. PMID: 1400299
-
Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.J Clin Invest. 1984 Jun;73(6):1550-6. doi: 10.1172/JCI111361. J Clin Invest. 1984. PMID: 6609936 Free PMC article.
-
Roles of platelets and factor XI in the initiation of blood coagulation by thrombin.Thromb Haemost. 2001 Jul;86(1):75-82. Thromb Haemost. 2001. PMID: 11487044 Review.
-
Activation of factor IX by factor XIa.Trends Cardiovasc Med. 2000 Jul;10(5):198-204. doi: 10.1016/s1050-1738(00)00070-0. Trends Cardiovasc Med. 2000. PMID: 11282295 Review.
Cited by
-
The foundation for investigating factor XI as a target for inhibition in human cardiovascular disease.J Thromb Thrombolysis. 2024 Dec;57(8):1283-1296. doi: 10.1007/s11239-024-02985-0. Epub 2024 Apr 25. J Thromb Thrombolysis. 2024. PMID: 38662114 Free PMC article. Review.
-
Factor XI: structure, function and therapeutic inhibition.J Thromb Thrombolysis. 2024 Dec;57(8):1315-1328. doi: 10.1007/s11239-024-02972-5. Epub 2024 Apr 16. J Thromb Thrombolysis. 2024. PMID: 38622277 Free PMC article. Review.
-
Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.J Clin Invest. 1987 Dec;80(6):1578-86. doi: 10.1172/JCI113244. J Clin Invest. 1987. PMID: 3500185 Free PMC article.
-
The many faces of the contact pathway and their role in thrombosis.J Thromb Thrombolysis. 2011 Jul;32(1):9-20. doi: 10.1007/s11239-011-0578-5. J Thromb Thrombolysis. 2011. PMID: 21404067 Review.
-
Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go?Curr Cardiol Rep. 2010 Jul;12(4):315-20. doi: 10.1007/s11886-010-0117-6. Curr Cardiol Rep. 2010. PMID: 20432072 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources